Cibisatamab - CAS 1855925-27-7

Cibisatamab is a T-cell bispecific antibody that acts as a T-cell splicer.Cibisatamab targets carcinoembryonic antigen (CEA) on cancer cells and CD3 on T-cells, and triggers T-cell killing when the CEA on the surface of the cancer cells ranges from intermediate to high levels.Cibisatamab may be used to study solid cancers such as colorectal cancer.

Others, Integrin

Cytoskeletal Signaling, Others

1855891

>99.1%

-20°C

Ice Packs

Inhibitory Antibodies